Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-12

Clinical Trial Update: Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether Exenatide affects liver fat content in people with Type 2 Diabetes Mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2016-04-12